Research.Patient.info
Non-alcoholic steatohepatitis (NASH) research hub
2 indexed studies · 1 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo-controlled trial.
This study is looking at new treatments for a liver condition called NASH. Researchers want to see if combining two medicines can improve liver scarring and damage. They will also check if the treatments are safe for people with NASH.
Germany · France · Italy - active not recruitingPHASE4
Combined Active Treatment in Type 2 Diabetes with NASH
This study is looking at new ways to treat a liver condition called NASH in people with type 2 diabetes. We're testing two medicines, empagliflozin and semaglutide, to see if they can help improve liver health. This is important because there are currently no specific treatments for NASH.
Austria · Germany